News
Show news feed

Donald Trump’s victory in the presidential election has saved the US Biotech sector, American-Armenian marketing specialist Todd Hagopian told Forbes business magazine.

In his view, had candidate Hillary Clinton and the Democratic Party won the presidential race, they would have started a price control in this sector.

Hagopian added that, due to expectations of a Clinton win, the value of the shares of Biotech companies had fallen, over the past several months.

But now, as per the expert, an opportunity is being created for new medical drugs, and there is no need to fear a strict price oversight of these drugs.

!
This text available in   Հայերեն and Русский
Print
Photos